Valuation: BICO Group AB

Market Cap 1.76B 175M 157M 146M 133M 249M 16.61B 251M 686M 8.62B 655M 641M 27.72B P/E 2026 *
-7.73x
P/E 2027 * -13.9x
Enterprise Value 1.69B 168M 151M 141M 128M 239M 15.96B 241M 659M 8.28B 629M 616M 26.63B EV / Sales 2026 *
1.04x
EV / Sales 2027 * 0.94x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day+39.45%
1 week+39.45%
Current month+39.45%
1 month+91.65%
3 months+41.36%
6 months+20.65%
Current year+27.24%
1 week 0.71
Extreme 0.7068
0.71
1 month 0.51
Extreme 0.506856
0.71
Current year 0.35
Extreme 0.35
0.71
1 year 0.35
Extreme 0.35
0.75
3 years 0.35
Extreme 0.35
1.55
5 years 0.35
Extreme 0.35
13.31
10 years 0.35
Extreme 0.35
14.8
Manager TitleAgeSince
Chief Executive Officer 51 2026-08-31
Director of Finance/CFO 56 2026-02-28
Chief Operating Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 71 2019-12-17
Director/Board Member 37 2015-02-28
Director/Board Member 51 2026-05-06
Change 5-day change 1-year change 3-year change Capi.($)
+39.45%+39.45% - - 175M
+1.53%+1.68%+28.03%+39.42% 249B
+0.83%+2.84%+8.99%+7.29% 158B
-0.43%+1.38%-3.70%+53.85% 148B
-0.72%+3.42%-55.32%-13.17% 62.32B
-0.11%+4.70%-14.98%-15.96% 49.61B
+1.38%+0.78%+17.84%+22.14% 49.83B
-1.42%+5.26%+3.37%+37.59% 48.14B
+1.40%+2.90%+26.05%+57.45% 49.06B
+1.73%+0.14%+31.06%+72.84% 42.9B
Average +4.41%+2.20%+4.59%+29.05% 95.24B
Weighted average by Cap. +0.67%+1.95%+8.54%+30.57%

Financials

2026 *2027 *
Net sales 1.62B 161M 145M 135M 122M 230M 15.33B 231M 633M 7.96B 605M 592M 25.59B 1.69B 167M 150M 140M 127M 239M 15.93B 240M 658M 8.27B 628M 615M 26.59B
Net income -227M -22.54M -20.27M -18.92M -17.14M -32.19M -2.15B -32.39M -88.64M -1.11B -84.64M -82.8M -3.58B -126M -12.51M -11.25M -10.5M -9.52M -17.87M -1.19B -17.98M -49.2M -618M -46.98M -45.96M -1.99B
Net Debt -69M -6.85M -6.16M -5.75M -5.21M -9.78M -652M -9.84M -26.94M -338M -25.73M -25.17M -1.09B -166M -16.49M -14.82M -13.83M -12.54M -23.54M -1.57B -23.68M -64.82M -814M -61.89M -60.55M -2.62B
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
24.90SEK
Average target price
29.00SEK
Spread / Average Target
+16.47%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BICO Group AB